Citi trims PT for Australia's Ramsay Health Care on lower UK forecasts

Ramsay Health Care

30/03/2026 19:40

** Citi trims price target for Ramsay Health Care RHC.AX to A$39 from A$41.40

** Brokerage sees Sante, RHC's long-underperforming French-listed business, contributing very little to Sydney-based hospital operator's EPS in FY27

** Sante is scheduled to leave business in late 2026, subject to approvals

** Citi sees lower revenue growth for UK hospitals business, readacross from RHC's competitor Spire in past weeks

** Brokerage trims revenue growth rates estimate for RHC's UK hospitals business to -7% in 2H26 from 3%, on constant currency basis

** Investor interest levels are up but our PT is slightly down on lower UK forecasts and a tough environment in

France, Citi says

** Three of 14 analysts rate stock "buy", ten "hold" and one "sell"; their median PT is A$42.90 – LSEG data

** YTD, RHC up 16% as of last close

 (Reporting by Sherin Sunny in Bengaluru)

 ((Sherin.Sunny@thomsonreuters.com))